EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ferroptosis in Doxorubicin-Induced Cardiotoxicity: From Molecular Mechanisms to Therapeutic Strategies and Clinical Management Paradigms

Peipei Zhang iD, Zilong Wu iD, Xiaoying Pan iD, Xinyi Chen iD, Weinian Xia iD, Zhuan Peng iD, Changyu Zhou iD, Jie Xiang iD, Li Wang, Dezhong Li, Kai Luo iD, Chuying Huang iD

Reviews in Cardiovascular Medicine · 17.06.2026 · 27 (6)

DOI: 10.31083/rcm46166 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 17.06.2026. Verfasst von Peipei Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory for Translational Research in Traditional Chinese Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of Hubei Provincial Administration of Traditional Chinese Medicine, Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite substantial advances in oncology and cardiovascular research, the clinical use of doxorubicin (DOX) remains constrained by significant cardiotoxicity; meanwhile, ferroptosis is now recognized as a central mechanism underlying DOX-induced cardiotoxicity (DIC). DOX disrupts myocardial iron homeostasis, impairs key antioxidant defense systems, and induces lipid metabolic reprogramming that promotes the accumulation of peroxidation-prone substrates, driving excessive lipid peroxidation and ferroptotic cell death. Ferroptosis also closely interacts with apoptosis, pyroptosis, and related pathways, forming a synergistic cell death network characterized by PANoptosis, which exacerbates cardiac injury. An integrated strategy encompassing primary prevention, targeted inhibition of core ferroptotic pathways, and systemic cardiac repair has emerged, which includes cardiac-targeted nanodelivery systems, selective inhibitors of key regulators such as glutathione peroxidase 4 (GPX4), ferroptosis suppressor protein 1 (FSP1), and acyl-CoA synthetase long-chain family member 4, as well as pharmacological activation of endogenous cardioprotective pathways. Clinical monitoring is also evolving from conventional cardiac functional indices toward early-warning approaches that incorporate ferroptosis-related circulating biomarkers, such as stress products, sensitive imaging metrics, including global longitudinal strain (GLS), and artificial intelligence-assisted analyses. Therefore, this review provides a systematic and comprehensive synthesis of recent advances in the molecular mechanisms, therapeutic interventions, and clinical management frameworks of ferroptosis in DIC, aiming to deepen understanding of the role of this process in the pathogenesis and treatment of DOX-induced cardiac injury.

Schlagwörter

Stichwörter der Autor:innen

biomarkerscardiotoxicitydisease managementdoxorubicinferroptosis

Autor:innen und Institutionen

  • Hubei Key Laboratory for Translational Research in Traditional Chinese Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Hubei Minzu University, 445000 Enshi, Hubei, China.
  • College of Biological and Food Engineering, Hubei Minzu University, 445000 Enshi, Hubei, China.
  • School of Public Health, Xiamen University, 361100 Xiamen, Fujian, China.
  • Cardiovascular Disease Center, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi Clinical College of Wuhan University, 445000 Enshi, Hubei, China.

ORCID-Profile: Peipei Zhang, Zilong Wu, Xiaoying Pan, Xinyi Chen, Weinian Xia, Zhuan Peng, Changyu Zhou, Jie Xiang, Kai Luo, Chuying Huang

Förderung

  • National Natural Science Foundation of China
  • Project of Hubei Provincial Administration of Traditional Chinese Medicine
  • Natural Science Foundation of Hubei Province

Zitieren

APA

Zhang, P., Wu, Z., Pan, X., Chen, X., Xia, W., Peng, Z., Zhou, C., Xiang, J., Wang, L., Li, D., Luo, K., & Huang, C. (2026). Ferroptosis in Doxorubicin-Induced Cardiotoxicity: From Molecular Mechanisms to Therapeutic Strategies and Clinical Management Paradigms. Reviews in Cardiovascular Medicine, 27(6). https://doi.org/10.31083/rcm46166

Vancouver

Zhang P, Wu Z, Pan X, Chen X, Xia W, Peng Z, et al. Ferroptosis in Doxorubicin-Induced Cardiotoxicity: From Molecular Mechanisms to Therapeutic Strategies and Clinical Management Paradigms. Reviews in Cardiovascular Medicine. 2026;27(6). doi:10.31083/rcm46166

BibTeX
@article{Zhang2026,
  author = {Zhang, Peipei and Wu, Zilong and Pan, Xiaoying and Chen, Xinyi and Xia, Weinian and Peng, Zhuan and Zhou, Changyu and Xiang, Jie and Wang, Li and Li, Dezhong and Luo, Kai and Huang, Chuying},
  title = {Ferroptosis in Doxorubicin-Induced Cardiotoxicity: From Molecular Mechanisms to Therapeutic Strategies and Clinical Management Paradigms},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2026},
  volume = {27},
  number = {6},
  doi = {10.31083/rcm46166}
}
Kostenlos starten →